The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Open accessAbstract
Vascular disrupting agents such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) represent a novel approach for cancer treatment. DMXAA has potent antitumor activity in mice and, despite significant preclinical promise, failed human clinical trials. The antitumor activity of DMXAA has been linked to its ability to induce type I IFNs in macrophages, although the molecular mechanisms involved are poorly understood. In this study, we identify stimulator of IFN gene (STING) as a direct receptor for DMXAA leading to TANK-binding kinase 1 and IFN regulatory factor 3 signaling. Remarkably, the ability to sense DMXAA was restricted to murine STING. Human STING failed to bind to or signal in response to DMXAA. Human STING also failed to signal in response to cyclic dinucleotides, conserved bacterial second messengers known to bind and activate murine STING signaling. Collectively, these findings detail an unexpected species-specific role for STING as a receptor for an anticancer drug and uncover important insights that may explain the failure of DMXAA in clinical trials for human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Self-citationSTING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
Self-citationAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Self-citationTriggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G.-P., Lin, R., & Hiscott, J. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,661
Self-citationIFI16 is an innate immune sensor for intracellular DNA
Unterholzner, L., Keating, S. E., Baran, M., Horan, K. A., Jensen, S. B., Sharma, S., Sirois, C. M., Jin, T., Latz, E., Xiao, T. S., et al. (2010) · Nature Immunology · doi:10.1038/ni.1932 · Cited by 1,643
Self-citationInterferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
STING is a direct innate immune sensor of cyclic di-GMP
Burdette, D. L., Monroe, K. M., Sotelo-Troha, K., Iwig, J. S., Eckert, B., Hyodo, M., Hayakawa, Y., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10429 · Cited by 1,570
Self-citationThe AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Rathinam, V. A. K., Jiang, Z., Waggoner, S. N., Sharma, S., Cole, L. E., Waggoner, L., Vanaja, S. K., Monks, B. G., Ganesan, S., Latz, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1864 · Cited by 1,331
Self-citationSTING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway
Tanaka, Y., & Chen, Z. J. (2012) · Science Signaling · doi:10.1126/scisignal.2002521 · Cited by 1,317
RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
Chiu, Y.-H., MacMillan, J. B., & Chen, Z. J. (2009) · Cell · doi:10.1016/j.cell.2009.06.015 · Cited by 1,174
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
Toll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Ablasser, A., Bauernfeind, F., Hartmann, G., Latz, E., Fitzgerald, K. A., & Hornung, V. (2009) · Nature Immunology · doi:10.1038/ni.1779 · Cited by 893
Self-citationRole of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells
Zhang, Z., Yuan, B., Bao, M., Lu, N., Kim, T., & Liu, Y.-J. (2011) · Nature Immunology · doi:10.1038/ni.2091 · Cited by 877
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
Roberts, T. L., Idris, A., Dunn, J. A., Kelly, G. M., Burnton, C. M., Hodgson, S., Hardy, L. L., Garceau, V., Sweet, M. J., Ross, I. L., et al. (2009) · Science · doi:10.1126/science.1169841 · Cited by 830
Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, A., Yamamoto, M., Akira, S., & Fitzgerald, K. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5260 · Cited by 643
Self-citationMcWhirter, S. M., Fitzgerald, K. A., Rosains, J., Rowe, D. C., Golenbock, D. T., & Maniatis, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237236100 · Cited by 540
Self-citationSauer, J.-D., Sotelo-Troha, K., von Moltke, J., Monroe, K. M., Rae, C. S., Brubaker, S. W., Hyodo, M., Hayakawa, Y., Woodward, J. J., Portnoy, D. A., et al. (2011) · Infection and Immunity · doi:10.1128/iai.00999-10 · Cited by 539
Self-citationSingh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., & Fidler, I. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4562 · Cited by 440
Parvatiyar, K., Zhang, Z., Teles, R. M., Ouyang, S., Jiang, Y., Iyer, S. S., Zaver, S. A., Schenk, M., Zeng, S., Zhong, W., et al. (2012) · Nature Immunology · doi:10.1038/ni.2460 · Cited by 406
Type I interferon response and innate immune sensing of cancer
Fuertes, M. B., Woo, S.-R., Burnett, B., Fu, Y.-X., & Gajewski, T. F. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.004 · Cited by 375
Ouyang, S., Song, X., Wang, Y., Ru, H., Shaw, N., Jiang, Y., Niu, F., Zhu, Y., Qiu, W., Parvatiyar, K., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.019 · Cited by 350
Shu, C., Yi, G., Watts, T., Kao, C. C., & Li, P. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2331 · Cited by 305
Cyclic di-GMP Sensing via the Innate Immune Signaling Protein STING
Yin, Q., Tian, Y., Kabaleeswaran, V., Jiang, X., Tu, D., Eck, M. J., Chen, Z. J., & Wu, H. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.029 · Cited by 278
Dinney, C. P., Bielenberg, D. R., Perrotte, P., Reich, R., Eve, B. Y., BUCANA, C. D., & Fidler, I. J. (1998) · PubMed · Cited by 271
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van Damme, J., & Kunkel, S. L. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.752 · Cited by 250
Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP
Shang, G., Zhu, D., Li, N., Zhang, J., Zhu, C., Lu, D., Liu, C., Yu, Q., Zhao, Y., Xu, S., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2332 · Cited by 233
Prantner, D., Perkins, D. J., Lai, W., Williams, M. S., Sharma, S., Fitzgerald, K. A., & Vogel, S. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382986 · Cited by 216
Self-citationThe structural basis for the sensing and binding of cyclic di-GMP by STING
Huang, Y.-H., Liu, X.-Y., Du, X.-X., Jiang, Z.-F., & Su, X.-D. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2333 · Cited by 213
Self-citationAntivascular therapy of cancer: DMXAA
Baguley, B. C. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01018-0 · Cited by 187
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
Roberts, Z. J., Goutagny, N., Perera, P.-Y., Kato, H., Kumar, H., Kawai, T., Akira, S., Savan, R., van Echo, D., Fitzgerald, K. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061845 · Cited by 169
Self-citationJassar, A. S., Suzuki, E., Kapoor, V., Sun, J., Silverberg, M. B., Cheung, L., Burdick, M. D., Strieter, R. M., Ching, L., Kaiser, L. R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1658 · Cited by 148
Jameson, M. B., Thompson, P. I., Baguley, B. C., Evans, B. D., Harvey, V. J., Porter, D. J. T., McCrystal, M. R., Small, M., Bellenger, K., Gumbrell, L. A., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600992 · Cited by 136
The STING pathway and regulation of innate immune signaling in response to DNA pathogens
Ishikawa, H., & Barber, G. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0605-2 · Cited by 133
Philpott, M., Baguley, B. C., & Ching, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689199 · Cited by 108
Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours
Smith, G. P., Calveley, S. B., Smith, M. J., & Baguley, B. C. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90157-x · Cited by 95
McKeage, M. J., Reck, M., Jameson, M. B., Rosenthal, M. A., Gibbs, D. D., Mainwaring, P. N., Freitag, L., Sullivan, R., & von Pawel, J. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.027 · Cited by 93
Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.
Gresser, I., Belardelli, F., Maury, C., Maunoury, M. T., & Tovey, M. G. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.158.6.2095 · Cited by 93
Role of toll-like receptors in tissue repair and tumorigenesis
Rakoff-Nahoum, S., & Medzhitov, R. M. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908050088 · Cited by 92
Ching, L.-M., Goldsmith, D., Joseph, W. R., Körner, H., Sedgwick, J. D., & Bc, B. (1999) · PubMed · Cited by 87
Immunomodulatory Actions of Xanthenone Anticancer Agents
Baguley, B. C., & Ching, L. (1997) · BioDrugs · doi:10.2165/00063030-199708020-00005 · Cited by 60
Wang, L. S., Thomsen, L., Sutherland, R., Reddy, C. B., Tijono, S., Chen, C. J., Angel, C. E., Dunbar, P. R., & Ching, L. (2009) · Neoplasia · doi:10.1593/neo.09506 · Cited by 48
Barber, G. N. (2011) · Nature Immunology · doi:10.1038/ni.2118 · Cited by 48
Perera, P., Barber, S. A., Ching, L., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4684 · Cited by 47
The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer
McKeage, M. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.1.23 · Cited by 45
Wallace, A. F., LaRosa, D. F., Kapoor, V., Sun, J., Cheng, G., Jassar, A. S., Blouin, A., Ching, L., & Albelda, S. Μ. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3757 · Cited by 44
Head, M., & Jameson, M. B. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903540214 · Cited by 40
Roberts, Z. J., Ching, L., & Vogel, S. N. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0992 · Cited by 34
Self-citationChing, L., Young, H. A., Eberly, K., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00194-x · Cited by 16
Sun, J., Wang, L. S., Fridlender, Z. G., Kapoor, V., Cheng, G., Ching, L., & Albelda, S. Μ. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.086 · Cited by 16
Woon, S., Hung, S. S. C., Wu, D. C. F., Schooltink, M. A., Sutherland, R., Baguley, B. C., Chen, Q., Chamley, L. W., & Ching, L.-M. (2007) · PubMed · Cited by 11
Nucleic acids recognition by innate immunity
Akira, S., Saitoh, T., & Kawai, T. (2012) · Uirusu · doi:10.2222/jsv.62.39 · Cited by 8
TLR family and viral infection
Uematsu, S., & Akira, S. (2004) · Uirusu · doi:10.2222/jsv.54.145 · Cited by 5
Cited by
Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
Chen, Q., Sun, L., & Chen, Z. J. (2016) · Nature Immunology · doi:10.1038/ni.3558 · Cited by 2,333
CGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING.
Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Röhl, I., Hopfner, K.-P., Ludwig, J., & Hornung, V. (2013) · Nature · doi:10.1038/nature12306 · Cited by 1,695
Corrales, L., Glickman, L. H., McWhirter, S. M., Kanne, D. B., Sivick, K. E., Katibah, G. E., Woo, S.-R., Lemmens, E., Banda, T., Leong, J. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.031 · Cited by 1,560
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Yi, M., Zheng, X., Niu, M., Zhu, S., Ge, H., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01489-2 · Cited by 1,445
The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
Li, T., & Chen, Z. J. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180139 · Cited by 1,293
Metadata
- Authors
- Conlon, J., Burdette, D. L., Sharma, S., Bhat, N., Thompson, M., Jiang, Z., Rathinam, V. A. K., Monks, B., Jin, T., Xiao, T. S., Vogel, S. N., Vance, R. E., & Fitzgerald, K. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05
- Volume
- 190
- Issue
- 10
- Pages
- 5216-5225
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1866003637
- Cited by
- 434
- References
- 56
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.